New schedule of bevacizumab/paclitaxel as first‐line therapy for metastatic HER2‐negative breast cancer in a real‐life setting

অনুযায়ী Cannita, Katia, Paradisi, Stefania, Cocciolone, Valentina, Bafile, Alberto, Rinaldi, Lucia, Irelli, Azzurra, Lanfiuti Baldi, Paola, Zugaro, Luigi, Manetta, Rosa, Alesse, Edoardo, Ricevuto, Enrico, Ficorella, Corrado
প্রকাশিত Cancer Med (2016)

Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis

অনুযায়ী Cocciolone, Valentina, Cannita, Katia, Calandrella, Maria Letizia, Ricevuto, Enrico, Baldi, Paola Lanfiuti, Sidoni, Tina, Irelli, Azzurra, Paradisi, Stefania, Pizzorno, Laura, Resta, Valter, Bafile, Alberto, Alesse, Edoardo, Tessitore, Alessandra, Ficorella, Corrado
প্রকাশিত Oncotarget (2017)

Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations

অনুযায়ী Cocciolone, Valentina, Cannita, Katia, Tessitore, Alessandra, Mastroiaco, Valentina, Rinaldi, Lucia, Paradisi, Stefania, Irelli, Azzurra, Baldi, Paola Lanfiuti, Sidoni, Tina, Ricevuto, Enrico, Dal Mas, Antonella, Calvisi, Giuseppe, Coletti, Gino, Ciccozzi, Antonietta, Pizzorno, Laura, Resta, Valter, Bafile, Alberto, Alesse, Edoardo, Ficorella, Corrado
প্রকাশিত Oncotarget (2018)